Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1501 AL 1515

A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin

Younas N, Fernandez Flores LC, Hopfner F, Höglinger GU, Zerr I.

Transl Neurodegener. 2022 May 9;11(1):28. doi: 10.1186/s40035-022-00301-5.

Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update

McFarthing K, Rafaloff G, Baptista M, Mursaleen L, Fuest R, Wyse RK, Stott SRW.

J Parkinsons Dis. 2022;12(4):1073-1082. doi: 10.3233/JPD-229002.

The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects From NEDA Use in Early Parkinson's Disease: Evidence From Clinical Trials

Wu C, Guo H, Xu Y, Li L, Li X, Tang C, Chen D, Zhu M.

Front Aging Neurosci. 2022 Apr 22;14:831884. doi: 10.3389/fnagi.2022.831884. eCollection 2022.

The Many Faces of Blurry Vision in Parkinson's Disease: An Illustrative Case Series

Borm CDJM, Bloem BR, Hoyng C, de Vries NM, Theelen T.

Case Rep Neurol. 2022 Mar 29;14(1):173-178. doi: 10.1159/000523987. eCollection 2022 Jan-Apr.

Hitchhiker's guide through the axon: transport and local translation of Pink1 mRNA support axonal mitophagy

Metur SP, Klionsky DJ.

Autophagy. 2022 May;18(5):947-948. doi: 10.1080/15548627.2022.2071081. Epub 2022 May 9.

Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes

Hezemans FH, Wolpe N, O'Callaghan C, Ye R, Rua C, Jones PS, Murley AG, Holland N, Regenthal R, Tsvetanov KA, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB.

PLoS Comput Biol. 2022 May 9;18(5):e1010079. doi: 10.1371/journal.pcbi.1010079. eCollection 2022 May.

A brief history of brain iron accumulation in Parkinson disease and related disorders

Foley PB, Hare DJ, Double KL.

J Neural Transm (Vienna). 2022 Jun;129(5-6):505-520. doi: 10.1007/s00702-022-02505-5. Epub 2022 May 9.

Idiopathic Parkinson's disease and chronic pain in the era of deep brain stimulation: a systematic review and meta-analysis

Flouty O, Yamamoto K, Germann J, Harmsen IE, Jung HH, Cheyuo C, Zemmar A, Milano V, Sarica C, Lozano AM.

J Neurosurg. 2022 Apr 29;137(6):1821-1830. doi: 10.3171/2022.2.JNS212561. Print 2022 Dec 1.

Telomerase and neurons: an unusual relationship

Saretzki G.

Neural Regen Res. 2022 Nov;17(11):2364-2367. doi: 10.4103/1673-5374.336133.

Lipopolysaccharide mouse models for Parkinson's disease research: a critical appraisal

Deng I, Bobrovskaya L.

Neural Regen Res. 2022 Nov;17(11):2413-2417. doi: 10.4103/1673-5374.331866.

Emerging targets signaling for inflammation in Parkinson's disease drug discovery

Khairnar RC, Parihar N, Prabhavalkar KS, Bhatt LK.

Metab Brain Dis. 2022 Oct;37(7):2143-2161. doi: 10.1007/s11011-022-00999-2. Epub 2022 May 10.

Histamine and Microglia

Iida T, Yanai K, Yoshikawa T.

Curr Top Behav Neurosci. 2022;59:241-259. doi: 10.1007/7854_2022_322.

Adaptive changes in striatal projection neurons explain the long duration response and the emergence of dyskinesias in patients with Parkinson's disease

Falkenburger B, Kalliakoudas T, Reichmann H.

J Neural Transm (Vienna). 2022 Jun;129(5-6):497-503. doi: 10.1007/s00702-022-02510-8. Epub 2022 May 10.

Amantadine therapy for Parkinson's Disease: In Vivo Confocal Microscopy corneal findings, case report and revision of literature

Cennamo M, Dragotto F, Favuzza E, Morelli A, Mencucci R.

BMC Ophthalmol. 2022 May 10;22(1):211. doi: 10.1186/s12886-022-02410-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias